Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine.
Antonio M, Dada-Adegbola H, Biney E, Awine T, O'Callaghan J, Pfluger V, Enwere G, Okoko B, Oluwalana C, Vaughan A, Zaman SM, Pluschke G, Greenwood BM, Cutts F, Adegbola RA. Antonio M, et al. Among authors: vaughan a. BMC Infect Dis. 2008 Jun 11;8:81. doi: 10.1186/1471-2334-8-81. BMC Infect Dis. 2008. PMID: 18547404 Free PMC article.
Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri.
Ikumapayi UN, Antonio M, Sonne-Hansen J, Biney E, Enwere G, Okoko B, Oluwalana C, Vaughan A, Zaman SMA, Greenwood BM, Cutts FT, Adegbola RA. Ikumapayi UN, et al. Among authors: vaughan a. J Med Microbiol. 2007 Nov;56(Pt 11):1479-1484. doi: 10.1099/jmm.0.47416-0. J Med Microbiol. 2007. PMID: 17965348
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group. Cutts FT, et al. Among authors: vaughan a. Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. doi: 10.1016/S0140-6736(05)71876-6. Lancet. 2005. PMID: 15794968 Clinical Trial.
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia.
Saaka M, Okoko BJ, Kohberger RC, Jaffar S, Enwere G, Biney EE, Oluwalana C, Vaughan A, Zaman SM, Asthon L, Goldblatt D, Greenwood BM, Cutts FT, Adegbola RA. Saaka M, et al. Among authors: vaughan a. Vaccine. 2008 Jul 4;26(29-30):3719-26. doi: 10.1016/j.vaccine.2008.04.066. Epub 2008 May 16. Vaccine. 2008. PMID: 18514974 Clinical Trial.
Measuring Growth, Resistance, and Recovery after Artemisinin Treatment of Plasmodium falciparum in a single semi-high-throughput Assay.
Sievert MAC, Singh PP, Shoue DA, Checkley LA, Brenneman KM, Qahash T, Cassady Z, Kumar S, Li X, Nosten FH, Anderson TJC, Vaughan AM, Romero-Severson J, Ferdig MT. Sievert MAC, et al. Among authors: vaughan am. bioRxiv [Preprint]. 2024 Nov 11:2024.11.11.623064. doi: 10.1101/2024.11.11.623064. bioRxiv. 2024. PMID: 39605531 Free PMC article. Preprint.
705 results